Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $834.3 million.

  • Cellebrite DI's Liabilities and Shareholders Equity rose 3259.03% to $834.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 3444.85%. This contributed to the annual value of $690.6 million for FY2024, which is 2959.02% up from last year.
  • Latest data reveals that Cellebrite DI reported Liabilities and Shareholders Equity of $834.3 million as of Q3 2025, which was up 3259.03% from $787.4 million recorded in Q2 2025.
  • Cellebrite DI's Liabilities and Shareholders Equity's 5-year high stood at $834.3 million during Q3 2025, with a 5-year trough of $315.1 million in Q3 2021.
  • For the 5-year period, Cellebrite DI's Liabilities and Shareholders Equity averaged around $508.6 million, with its median value being $476.9 million (2023).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 675.22% in 2021, then surged by 4147.49% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Liabilities and Shareholders Equity stood at $339.8 million in 2021, then increased by 18.69% to $403.3 million in 2022, then soared by 32.13% to $532.9 million in 2023, then grew by 29.59% to $690.6 million in 2024, then increased by 20.82% to $834.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $834.3 million for Q3 2025, versus $787.4 million for Q2 2025 and $709.9 million for Q1 2025.